Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of GID SVF-2 Device to Produce Autologous Adipose-Derived Stromal Vascular Fraction for Treatment of Osteoarthritis of the Knee: A Pivotal Medical Device Randomized Concurrent Controlled Study

NCT04440189 is registered in ClinicalTrials.gov with GID BIO, Inc. as lead sponsor.

NCT NCT04440189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04440189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of GID SVF-2 Device to Produce Autologous Adipose-Derived Stromal Vascular Fraction for Treatment of Osteoarthritis of the Knee: A Pivotal Medical Device Randomized Concurrent Controlled Study
Lead sponsor
GID BIO, Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 15, 2020
Completion date
June 30, 2025
Enrollment
114 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee